Marie Ballif
Overview
Explore the profile of Marie Ballif including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
958
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ballif M, Braun D, Calmy A, Bernasconi E, Cavassini M, Tissot F, et al.
BMJ Open
. 2024 Nov;
14(11):e094912.
PMID: 39578038
Introduction: Anti-retroviral therapy (ART) simplification strategies are needed for treatment-experienced people with HIV (PWH) and multidrug-resistant viruses. These individuals are commonly treated with boosted ART regimens and are thereby at...
2.
Jackson-Perry D, Cart-Richter E, Haerry D, Ahmeti L, Bieri A, Calmy A, et al.
J Int AIDS Soc
. 2024 Nov;
27(11):e26385.
PMID: 39528422
Introduction: Increasing evidence indicates the benefits of patient and public involvement (PPI) in medical research, and PPI is increasingly expected by funders and publishers. We conducted a mapping review of...
3.
Abela I, Chammartin F, Amstutz A, Surial B, Ballif M, Marzolini C, et al.
Open Forum Infect Dis
. 2024 Sep;
11(9):ofae502.
PMID: 39296341
The REPRIEVE trial suggests that primary cardiovascular disease (CVD) prevention could be considered among people with HIV at low CVD risk. We found cisgender women with low/moderate and high CVD...
4.
Zaniewski E, Skrivankova V, Brazier E, Avihingsanon A, Cardoso S, Cesar C, et al.
AIDS
. 2024 Sep;
38(15):2073-2085.
PMID: 39236112
Objective: We studied the transition to dolutegravir-containing antiretroviral therapy (ART) at HIV treatment clinics within the International epidemiology Databases to Evaluate AIDS (IeDEA). Design: Site-level survey conducted in 2020-2021 among...
5.
Nyakato P, Schomaker M, Boulle A, Euvrard J, Wood R, Eley B, et al.
Trop Med Int Health
. 2024 Jul;
29(8):739-751.
PMID: 38961819
Objectives: The objective of this study is to assess the outcomes of children, adolescents and young adults with HIV reported as lost to follow-up, correct mortality estimates for children, adolescents...
6.
Enane L, Duda S, Chanyachukul T, Bolton-Moore C, Navuluri N, Messou E, et al.
BMJ Open
. 2024 Jan;
14(1):e079138.
PMID: 38195167
Introduction: Tuberculosis (TB) is a leading infectious cause of death globally. It is the most common opportunistic infection in people living with HIV, and the most common cause of their...
7.
Skrivankova V, Hossmann S, Cornell M, Ballif M, Dupont C, Huwa J, et al.
BMJ Glob Health
. 2023 Dec;
8(12).
PMID: 38103897
Background: The International epidemiology Databases to Evaluate AIDS conducts research in several regions, including in Southern Africa. We assessed authorship inequalities for the Southern African region, which is led by...
8.
Zwyer M, Rutaihwa L, Windels E, Hella J, Menardo F, Sasamalo M, et al.
PLoS Pathog
. 2023 Apr;
19(4):e1010893.
PMID: 37014917
In settings with high tuberculosis (TB) endemicity, distinct genotypes of the Mycobacterium tuberculosis complex (MTBC) often differ in prevalence. However, the factors leading to these differences remain poorly understood. Here...
9.
Brazier E, Maruri F, Wester C, Musick B, Freeman A, Parcesepe A, et al.
PLoS One
. 2023 Mar;
18(3):e0268167.
PMID: 36917598
Introduction: Timely descriptions of HIV service characteristics and their evolution over time across diverse settings are important for monitoring the scale-up of evidence-based program strategies, understanding the implementation landscape, and...
10.
Zurcher K, Cox S, Ballif M, Enane L, Marcy O, Yotebieng M, et al.
PLOS Glob Public Health
. 2023 Feb;
2(3).
PMID: 36778080
Tuberculosis (TB) is the leading cause of death among PLHIV and multidrug-resistant-TB (MDR-TB) is associated with high mortality. We examined the management for adult PLHIV coinfected with MDR-TB at ART...